How SSR Supports Viscus Biologics’ Healing Tech
At Sustainable Swine Resources (SSR), we believe that collaboration drives innovation. One of our most impactful partnerships is with Viscus Biologics LLC, a leader in regenerative medicine.
Viscus Biologics develops porcine-derived extracellular matrix (ECM) components and products that support healing across a range of clinical applications, including wound care, hernia repair, dental, and orthopedic procedures. Their pioneering work is improving outcomes for patients and advancing the field of tissue regeneration.
Who is Viscus Biologics?
Viscus Biologics is a leader in regenerative technologies, creating ECM-based medical devices that support tissue repair and integration. These devices rely on porcine tissues such as dermis, small intestine submucosa, pericardium, peritoneum, and tendon—materials characterized by their tissue-specific architecture and bioactive molecules. Once decellularized, these tissues retain the structure and biological cues necessary to promote cellular infiltration, vascularization, and tissue regeneration in the patient.
The use of porcine-derived ECM offers a biologically active alternative to synthetic implants. Compared to their synthetic counterparts, these products are often better tolerated by the body and more effective in supporting natural healing processes.
The Value of Porcine ECM for Innovation and Outcomes
For Viscus Biologics, integrating porcine ECM into their portfolio has proven transformative, not only for business growth but also for patient care.
These products enable:
- Faster recovery times
- Reduced inflammation
- Better integration with host tissue
- Higher clinical satisfaction (providers and patients)
Because porcine ECM can be processed into multiple forms—sheets, gels, or powders—it lends itself to innovation across many therapeutic areas. This versatility supports Viscus Biologics’ ability to stay at the forefront of regenerative solutions.
As they shared with us:
“Incorporating porcine extracellular matrix (ECM) into a medical device portfolio can drive significant improvements in both company performance and patient outcomes. These devices and components often enable shorter recovery times, reduced inflammation, and improved tissue integration, leading to better clinical results and stronger physician preference.”
Delivering Real Benefits to Healthcare Providers and Patients
The impact of porcine ECM reaches well beyond the lab. Surgeons using Viscus Biologics products report improved handling, reduced operative time, and superior surgical site outcomes, especially in complex cases of wound healing. From a patient perspective, faster healing and reduced complications mean fewer setbacks and a better overall quality of life.
According to Viscus Biologics:
“Customers, clinicians and patients, have experienced notable benefits from the use of porcine ECM products. For healthcare providers, these materials offer a reliable, off-the-shelf solution that integrates well with host tissue and minimizes the need for synthetic implants or secondary procedures.”
A Strong Partnership with SSR
We’re proud to have played a role in supporting Viscus Biologics’ success. Through our ability to provide custom tissue sourcing and processing solutions, we’ve helped meet their exacting specifications in a tightly regulated industry.
Here’s what they had to say about working with us:
“Partnering with SSR has been instrumental to our success in developing high-quality porcine extracellular matrix-based medical devices and components. Their team has consistently demonstrated flexibility, adapting to our evolving needs and supporting custom tissue sourcing and processing solutions. The quality of their raw materials demonstrates consistent and well-characterized properties which are highly important in a regulated industry. What sets SSR apart is their responsiveness and collaborative spirit. They operate not just as a vendor, but as a partner. Their willingness to explore novel tissue types and innovative processing methods has expanded our product development possibilities and accelerated our time to market. We look forward to continuing this strong, solutions-focused partnership.”
At SSR, this kind of collaboration is exactly what drives us. We’re here to support life science innovators like Viscus Biologics, helping them bring better solutions to patients, providers, and the future of medicine.
Explore What’s Possible with SSR
At SSR, we’re your partner in progress. Whether you’re developing next-generation wound care solutions or advancing soft tissue technologies, our team is ready to help you bring innovation to life.
Contact us today to discuss how we can support your research, development, or product pipeline with high-quality porcine materials tailored to your needs.